Cargando…

L1CAM as a prognostic marker in stage I endometrial cancer: a validation study

BACKGROUND: L1 cell adhesion molecule (L1CAM) overexpression has been reported to be strongly associated with poor prognosis in early stage endometrial cancer (EC). We aimed at the validation of L1CAM as a marker of poor prognosis in an independent study population. METHODS: Patients with endometrio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smogeli, Elisabeth, Davidson, Ben, Cvancarova, Milada, Holth, Arild, Katz, Betina, Risberg, Bjørn, Kristensen, Gunnar, Lindemann, Kristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973089/ https://www.ncbi.nlm.nih.gov/pubmed/27488577 http://dx.doi.org/10.1186/s12885-016-2631-4

Ejemplares similares

Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial Cancer
por: Lindemann, Kristina, et al.
Publicado: (2021)

DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium
por: Pradhan, Manohar, et al.
Publicado: (2012)

Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma
por: Davidson, Ben, et al.
Publicado: (2023)

Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma
por: Davidson, Ben, et al.
Publicado: (2020)

CIAPIN1 and ABCA13 are markers of poor survival in metastatic ovarian serous carcinoma
por: Nymoen, Dag Andre, et al.
Publicado: (2015)

A study of chronic pelvic pain after radiotherapy in survivors of locally advanced cervical cancer
por: Vistad, Ingvild, et al.
Publicado: (2011)

Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification
por: Kasius, Jenneke C., et al.
Publicado: (2021)

Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinoma
por: Davidson, Ben, et al.
Publicado: (2020)

FIGO staging of endometrial cancer: 2023
por: Berek, Jonathan S., et al.
Publicado: (2023)

Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)
por: Lindemann, Kristina, et al.
Publicado: (2014)

Social support in early-stage breast cancer patients with fatigue
por: Sørensen, Hege Lilleskare, et al.
Publicado: (2020)

CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis
por: Torres, Anna, et al.
Publicado: (2019)

Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions
por: Davidson, Ben, et al.
Publicado: (2011)

Lifestyle and Empowerment Techniques in Survivorship of Gynaecologic Oncology (LETSGO study): a study protocol for a multicentre longitudinal interventional study using mobile health technology and biobanking
por: Vistad, Ingvild, et al.
Publicado: (2021)

Targeted Analysis of the Gut Microbiome for Diagnosis, Prognosis and Treatment Individualization in Pediatric Inflammatory Bowel Disease
por: Olbjørn, Christine, et al.
Publicado: (2022)

The impact of restrictions on psychological outcomes in patients with inflammatory bowel disease on biological treatment during the coronavirus pandemic in Norway
por: Opheim, Randi, et al.
Publicado: (2022)

High levels of preoperative pain and fatigue are red flags for moderate‐severe pain 12 months after total knee arthroplasty—A longitudinal cohort study
por: Getachew, Mestawet, et al.
Publicado: (2020)

Twelve-Months Follow-up of Supervised Exercise after Percutaneous Transluminal Angioplasty for Intermittent Claudication: A Randomised Clinical Trial
por: Bø, Elisabeth, et al.
Publicado: (2013)

Many Patients With Persistent Pain 1 Year After TKA Report Improvement by 5 to 7 Years: A Mixed-methods Study
por: Sellevold, Vibeke Bull, et al.
Publicado: (2022)

The sL1CAM in sera of patients with endometrial and ovarian cancers
por: Wojciechowski, Michał, et al.
Publicado: (2016)

L1CAM expression in endometrial carcinomas: an ENITEC collaboration study
por: van der Putten, Louis JM, et al.
Publicado: (2016)

Stages of change for physical activity and dietary habits in persons with type 2 diabetes included in a mobile health intervention: the Norwegian study in RENEWING HEALTH
por: Holmen, Heidi, et al.
Publicado: (2016)

Prognostic Value of β-Catenin and L1CAM Expressions in Type I Endometrial Carcinoma
por: Manule, Yolanda, et al.
Publicado: (2023)

Fish consumption and its possible preventive role on the development and prevalence of metabolic syndrome - a systematic review
por: Tørris, Christine, et al.
Publicado: (2014)

Nutrients in Fish and Possible Associations with Cardiovascular Disease Risk Factors in Metabolic Syndrome
por: Tørris, Christine, et al.
Publicado: (2018)

Lean Fish Consumption Is Associated with Beneficial Changes in the Metabolic Syndrome Components: A 13-Year Follow-Up Study from the Norwegian Tromsø Study
por: Tørris, Christine, et al.
Publicado: (2017)

Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma
por: Schirmer, Uwe, et al.
Publicado: (2014)

Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens
por: Schirmer, Uwe, et al.
Publicado: (2013)

Enhanced Risk Stratification in Early-Stage Endometrial Cancer: Integrating POLE through Droplet Digital PCR and L1CAM
por: Joe, Seungyeon, et al.
Publicado: (2023)

Prognostic value of pretreatment systemic inflammatory markers in patients with stage I endometrial cancer
por: Ahn, Jung Hwan, et al.
Publicado: (2022)

Mortality in Patients with Inflammatory Bowel Disease: Results from 30 Years of Follow-up in a Norwegian Inception Cohort (the IBSEN study)
por: Follin-Arbelet, Benoit, et al.
Publicado: (2022)

Risk of Cancer in Patients With Crohn’s Disease 30 Years After Diagnosis (the IBSEN Study)
por: Follin-Arbelet, Benoit, et al.
Publicado: (2023)

Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours
por: Westgaard, Arne, et al.
Publicado: (2009)

Diagnostic and Prognostic Values of Serum EpCAM, TGM2, and HE4 Levels in Endometrial Cancer
por: Lan, Ting, et al.
Publicado: (2020)

Teaching bioscience to nursing students—What works?
por: Knutstad, Unni, et al.
Publicado: (2020)

Correction to: Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens
por: Schirmer, Uwe, et al.
Publicado: (2018)

Update on Sentinel Lymph Node Biopsy in Surgical Staging of Endometrial Carcinoma
por: Eriksson, Ane Gerda Z, et al.
Publicado: (2021)

Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years
por: Barzenje, Dlawer Abdulla, et al.
Publicado: (2015)

Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium
por: Pradhan, M., et al.
Publicado: (2012)

Myoinvasive Pattern as a Prognostic Marker in Low-Grade, Early-Stage Endometrioid Endometrial Carcinoma
por: Ruz-Caracuel, Ignacio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ek6d551mle814he3th0a4radir